Home > Profile Articles > Members of Rohealth, OncoGen and the Clinical Hospital of Pneumology Iasi are part of the winning consortia of funding launched through competitive MEC / UEFISCDI for large projects with applications in research and treatment of the new Coronavirus

Members of Rohealth, OncoGen and the Clinical Hospital of Pneumology Iasi are part of the winning consortia of funding launched through competitive MEC / UEFISCDI for large projects with applications in research and treatment of the new Coronavirus

We have the pleasure and honor to congratulate the members of Rohealth, OncoGen and the Clinical Hospital of Pneumology Iasi, who are part of the winning consortia of funding launched through competitive MEC / UEFISCDI for large projects with applications in research and treatment of the new Coronavirus and budget of 3 millions of lei per consortium.

➡️The Oncogen Center is part of the winning consortium with a project worth RON 3.5 million to continue research for the vaccine against Covid-19, within the competition organized by the Ministry of Education and Research for the development of a vaccine against the SARS-nCov-2 virus.
More details on the page: www.oncogen.ro

➡️The Clinical Hospital of Pneumoftiziology Iasi and the University of Medicine and Pharmacy Gricore T. Popa from Iasi are part of the winning consortium within the Solution 1 - Innovative approaches in the treatment and control of patients infected with SARS-CoV-2 virus within the Ministry of Education and Research , with total funds amounting to RON 3,000,000.
More details on the page: https://uefiscdi.gov.ro/solutii-2020-abordari-inovative-in-tratamentu-si...

Good luck in implementation!

Share: